|
TLN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.174800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.074480E-02 |
| Normal-vs-Stage2 |
6.947800E-01 |
| Normal-vs-Stage3 |
7.032000E-01 |
| Normal-vs-Stage4 |
1.786830E-01 |
| Stage1-vs-Stage2 |
2.913700E-02 |
| Stage1-vs-Stage3 |
4.258900E-03 |
| Stage1-vs-Stage4 |
7.72770000000422E-05 |
| Stage2-vs-Stage3 |
9.251600E-01 |
| Stage2-vs-Stage4 |
4.708400E-01 |
| Stage3-vs-Stage4 |
3.310400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.429400E-01 |
| Normal-vs-AfricanAmerican |
4.652800E-01 |
| Normal-vs-Asian |
6.664600E-01 |
| Caucasian-vs-AfricanAmerican |
7.855200E-01 |
| Caucasian-vs-Asian |
7.527800E-01 |
| AfricanAmerican-vs-Asian |
8.718200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.554200E-01 |
| Normal-vs-Female |
9.693600E-02 |
| Male-vs-Female |
1.108380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.297000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.199800E-02 |
| Normal-vs-Age(61-80Yrs) |
8.787600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.609150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.095800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.133800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.923500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.018400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.648100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.908630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.03490000002981E-06 |
| Normal-vs-Grade 2 |
3.330200E-02 |
| Normal-vs-Grade 3 |
9.311200E-01 |
| Normal-vs-Grade 4 |
2.173600E-01 |
| Grade 1-vs-Grade 2 |
3.964000E-03 |
| Grade 1-vs-Grade 3 |
3.58289999999872E-05 |
| Grade 1-vs-Grade 4 |
9.08480000005873E-07 |
| Grade 2-vs-Grade 3 |
1.079670E-02 |
| Grade 2-vs-Grade 4 |
1.103340E-03 |
| Grade 3-vs-Grade 4 |
2.149600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.038700E-03 |
| Normal-vs-ccB subtype |
9.875400E-01 |
| ccA subtype-vs-ccB subtype |
8.138500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.749800E-01 |
| Normal-vs-N1 |
7.275200E-01 |
| N0-vs-N1 |
8.264200E-01 |
|
|
